Little, Milta O.
Hecker, Emily J.
Colon-Emeric, Cathleen S.
Herndon, Laurie
McConnell, Eleanor S.
Xue, Tingzhong Michelle
Berry, Sarah D.
Article History
Received: 17 June 2022
Accepted: 12 January 2023
First Online: 31 January 2023
Declarations
:
: This study, including the consent process, was performed in accordance with the Declaration of Helsinki and was reviewed and approved by the Institutional Review Boards of Hebrew Senior Life (Advarra) and Duke University. Informed consent to participate in this research study was obtained from all participants and/or their legal representatives.
: Details, images, or videos relating to an individual person were not included in the publication so consent for publication was not obtained.
: In the past 5 years, CCE has received funding from Amgen and UCB as endpoint adjudication chair, and as Data Safety Monitoring Chair for Novartis for drugs related to treatment of osteoporosis or osteosarcopenia. SDB received research funding from Amgen. No other authors have any conflict of interest.